GlaxoSmithKline (GSK)

Add to Watchlists Create an Alert
48.30 +0.27  +0.56% NYSE Jul 30, 1:14PM BATS Real time Currency in USD

GlaxoSmithKline Enterprise Value:

141.15B for None

View 4,000+ financial data types

View Full Chart

GlaxoSmithKline Enterprise Value Chart

Export Data
Save Image

GlaxoSmithKline Historical Enterprise Value Data

View and export this data going back to 1986. Start your YCharts Lite Membership
Export Data Date Range:
Viewing of   First  Previous First  Previous   Next  Last Next   Last
Data for this Date Range  
July 29, 2014 141.15B
July 28, 2014 141.56B
July 25, 2014 142.52B
July 24, 2014 146.08B
July 23, 2014 145.98B
July 22, 2014 153.62B
July 21, 2014 154.03B
July 18, 2014 154.82B
July 17, 2014 153.28B
July 16, 2014 153.84B
July 15, 2014 153.86B
July 14, 2014 154.48B
July 11, 2014 154.80B
July 10, 2014 156.45B
July 9, 2014 155.18B
July 8, 2014 153.96B
July 7, 2014 155.76B
July 3, 2014 156.74B
July 2, 2014 156.21B
July 1, 2014 155.95B
June 30, 2014 154.24B
June 27, 2014 154.61B
June 26, 2014 154.34B
June 25, 2014 153.74B
June 24, 2014 154.47B
   
June 23, 2014 154.83B
June 20, 2014 156.46B
June 19, 2014 156.19B
June 18, 2014 155.02B
June 17, 2014 155.27B
June 16, 2014 156.09B
June 13, 2014 156.36B
June 12, 2014 156.12B
June 11, 2014 155.87B
June 10, 2014 155.14B
June 9, 2014 154.81B
June 6, 2014 154.42B
June 5, 2014 153.45B
June 4, 2014 152.94B
June 3, 2014 153.25B
June 2, 2014 154.32B
May 30, 2014 155.00B
May 29, 2014 156.07B
May 28, 2014 154.61B
May 27, 2014 157.48B
May 23, 2014 157.18B
May 22, 2014 157.94B
May 21, 2014 158.35B
May 20, 2014 156.87B
May 19, 2014 157.18B

There is no data for the selected date range.

An error occurred. Please try again by refreshing your browser or contact us with details of your problem.

About Enterprise Value

Click "Learn More" below to see how YCharts calculates Enterprise Value.

Enterprise Value (EV) is a valuation metric alternative to traditional market capitalization that reflects the market value of an entire business. Like market cap, EV is a measure of what the market believes a company is worth. Enterprise value captures the cost of an entire business, including debt and equity. It is a sum of claims of all preferred shareholders, debt holders, security holders, common equity holders, and minority shareholders - unlike market cap, which only captures the total value of common equity securities.

EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Learn More

Get data for
Advertisement

GSK Enterprise Value Benchmarks

Companies
AstraZeneca 97.51B
Pfizer 193.06B
Novartis 227.24B

GSK Enterprise Value Range, Past 5 Years

Minimum 98.62B May 26 2010
Maximum 160.95B Apr 29 2014
Average 130.85B

GSK Enterprise Value Excel Add-In Codes

  • Metric Code: enterprise_value
  • Latest data point: =YCP("GSK", "enterprise_value")
  • Last 5 data points: =YCS("GSK", "enterprise_value", -4)

To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.

Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.

Advertisement

Already registered? Click here to sign in.

Access watchlists and custom data alerts.
Start your free account.

required
required
required
required
required
Get Started Now
document.write('');

{{root.upsell.info.feature_headline}}.
Upgrade to {{root.upsell.info.tier_name}}. Start your {{root.upsell.info.tier_name}} Membership

{{root.upsell.info.feature_description}}

{{root.upsell.info.is_upgrade ? "Upgrade Now" : "Start My Free Trial"}}

Already a {{root.upsell.info.tier_name}} Member? Sign in here.